A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS

被引：0
|
作者：
Balijepalli, C. [1 ]
Desai, K. [1 ]
Yan, K. [2 ]
Zoratti, M. [3 ]
Marshall, L. [4 ]
White, N. [5 ]
Franklin, M. [4 ]
Druyts, E. [1 ]
机构：
[1] Pharmalyt Grp, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Zoratti HEOR Consulting, Oakville, ON, Canada
[4] Franklin Pharmaceut Consulting LLC, Rock Hill, SC USA
[5] Franklin Pharmaceut Consulting LLC, Arlington, VA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PNS278
引用
收藏
页码：S810 / S810
页数：1
相关论文
共 50 条
  • [1] Health technology assessment of biosimilars worldwide: a scoping review
    Ascef, Bruna de Oliveira
    Lopes, Ana Carolina de Freitas
    de Soarez, Patricia Coelho
    HEALTH RESEARCH POLICY AND SYSTEMS, 2020, 18 (01)
  • [2] Health technology assessment of biosimilars worldwide: a scoping review
    Bruna de Oliveira Ascef
    Ana Carolina de Freitas Lopes
    Patrícia Coelho de Soárez
    Health Research Policy and Systems, 18
  • [3] Biosimilars: Evidential Standards for Health Technology Assessment
    Hughes, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (03) : 257 - 261
  • [4] Reimbursement of biosimilars in Poland: is there a link to health technology assessment?
    Neumann, Dominika
    Jablecka, Anna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 781 - 792
  • [5] Approval of biosimilars: a review of unsuccessful regulatory filings
    Rathore, Anurag S.
    Chhabra, Hemlata
    Bhargava, Ankita
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 19 - 27
  • [6] HEALTH TECHNOLOGY ASSESSMENT LANDSCAPE OF BIOSIMILARS - APPROACHES TO EVALUATIONS AND RESULTS
    Andreykiv, M.
    Dahal, D.
    VALUE IN HEALTH, 2013, 16 (03) : A4 - A4
  • [7] Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
    Grigore, Bogdan
    Ciani, Oriana
    Dams, Florian
    Federici, Carlo
    de Groot, Saskia
    Moellenkamp, Meilin
    Rabbe, Stefan
    Shatrov, Kosta
    Zemplenyi, Antal
    Taylor, Rod S.
    PHARMACOECONOMICS, 2020, 38 (10) : 1055 - 1070
  • [8] Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
    Bogdan Grigore
    Oriana Ciani
    Florian Dams
    Carlo Federici
    Saskia de Groot
    Meilin Möllenkamp
    Stefan Rabbe
    Kosta Shatrov
    Antal Zemplenyi
    Rod S. Taylor
    PharmacoEconomics, 2020, 38 : 1055 - 1070
  • [9] Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment
    Chugh, Yashika
    De Francesco, Maria
    Prinja, Shankar
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (06) : 825 - 838
  • [10] Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment
    Yashika Chugh
    Maria De Francesco
    Shankar Prinja
    Applied Health Economics and Health Policy, 2021, 19 : 825 - 838
12345